References
- Vivanco, I. and Sawyers, C.L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer 2, 489-501 (2002) https://doi.org/10.1038/nrc839
- Maehama, T., and Dixon, J.E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5,-triphosphate. J. Biol. Chem. 273, 13375-13378 (1998) https://doi.org/10.1074/jbc.273.22.13375
- Myers, M.P., Pass, I., Batty, I.H., Van der Kaay, J., Stolarov, J.P., Hemmings, B.A., Wigler, M.H., Downes, C.P., and Tonks, N.K. The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc. Natl. Acad. Sci. U.S.A. 95, 13513-13518 (1998)
- Tonks, N.K. and Myers, M.P. Structural assets of a tumor suppressor. Science 286, 2096-2097 (1999) https://doi.org/10.1126/science.286.5447.2096
- Samuels, Y. and Ericson, K. Oncogenic PI3K and its role in cancer. Curr. Opin. Oncol. 1, 77-82 (2006)
- Hennessy, B.T., Smith, D.L., Ram, P.T., Lu, Y., and Mills, G.B. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat. Rev. Drug Discov. 4, 988-1004 (2005) https://doi.org/10.1038/nrd1902
- Morgensztern, D. and McLeod, H.L. PI3K/Akt/mTOR pathway as a target for cancer therapy. Anticancer Drugs 16, 797-803 (2005) https://doi.org/10.1097/01.cad.0000173476.67239.3b
- Lachyankar, M.B., Sultana, N., Schonhoff, C.M., Mitra, P., Poluha, W., Lambert, S., Quesenberry, P.J., Litofsky, N.S., Recht, L.D., Nabi, R., Miller, S.J., Ohta, S., Neel, B.G., and Ross, A.H. A role for nuclear PTEN in neuronal differentiation. J. Neurosci. 20, 1404-1413 (2004)
- Kurose, K., Zhou, X.P., Araki, T., Cannistra, S.A., Maher, E.R., and Eng, C. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. Am. J. Pathol. 158, 2097-106 (2001) https://doi.org/10.1016/S0002-9440(10)64681-0
- Stambolic, V., MacPherson, D, Sas, D., Lin, Y., Snow, B., Jang, Y., Benchimol, S., and Mak, T.W. Regulation of PTEN transcription by p53. Mol. Cell 8, 317-325 (2001) https://doi.org/10.1016/S1097-2765(01)00323-9
- Sheng, X, Koul, D, Liu, JL, Liu, TJ, and Yung, W.K. Promoter analysis of tumor suppressor gene PTEN: identification of minimum promoter region. Biochem. Biophys. Res. Commun. 292, 422-426 (2002) https://doi.org/10.1006/bbrc.2002.6662
- Tang, Y, and Eng, C. PTEN autoregulates its expression by stabilization of p53 in a phosphatase-independent manner. Cancer Res. 66, 736-742 (2006) https://doi.org/10.1158/0008-5472.CAN-05-1557
-
Kim, S., Domon-Dell, C., Kang, J., Chung Dai H., Freund J., and Evers B.M. Down-regulation of the tumor suppressor PTEN by the tumor necrosis factor-/nuclear factor-
${\kappa}B$ (NF-${\kappa}B$ )-inducing kinase/NF-${\kappa}B$ pathway is linked to a default I-eB-autoregulatory loop. J. Biol. Chem. 279, 4285-4291 (2004) https://doi.org/10.1074/jbc.M308383200 - Lee, Y.R, Shim, H.J., Yu, H.N., Song, E.K., Park, J., Kwon, K.B., Park, J.W., Rho, H.W., Park, B.H., Han, M.K., and Kim, J.S. Dimethylsulfoxide induces upregulation of tumor suppressor protein PTEN through nuclear factor-kappaB activation in HL-60 cells. Leuk. Res. 29, 401-405 (2005) https://doi.org/10.1016/j.leukres.2004.09.010
- Arch, R.H. and Thompson, C.B. Lymphocyte survival--the struggle against. Annu. Rev. Cell Dev. Biol. 15, 113-114 (1999) https://doi.org/10.1146/annurev.cellbio.15.1.113
- Locksley, R.M., Killeen, N., and Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104, 487-501 (2001) https://doi.org/10.1016/S0092-8674(01)00237-9
- Peraldi, P. and Spiegelman, B. TNF-alpha and insulin resistance: summary and future prospects. Mol. Cell. Biochem. 182, 169-175 (1998) https://doi.org/10.1023/A:1006865715292
-
Chae, G.N. and Kwak, S.J. NF-
${\kappa}B$ is involved in the TNF-a induced inhibition of the differentiation of 3T3-L1 cells by reducing PPARg expression. Exp. Mol. Med. 35, 431-437 (2003) https://doi.org/10.1038/emm.2003.56 - Hsu, H., Huang, J., Shu, H.B., Baichwal, V., and Goeddel, D.V. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4, 387-396 (1996) https://doi.org/10.1016/S1074-7613(00)80252-6
- Hsu, H., Shu, H.B., Pan, M.G., and Goeddel, D.V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299-308 (1996) https://doi.org/10.1016/S0092-8674(00)80984-8
- Hsu, H, Xiong, J, and Goeddel, DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 81, 495-504 (1995) https://doi.org/10.1016/0092-8674(95)90070-5
- Gribanova, N.V., Rakitina, T.V., Zhokhov, S.S., Pustoshilova, N.M., Lipkin, V.M., and Kostanian, I.A. Lglutamic acid modulates the cytotoxic effect of tumor necrosis factor in the HL-60 cell line. Bioorg. Khim. 31, 602-608 (2005)
- Karin, M., and Lin, A. NF-kappaB at the crossroads of life and death. Nat. Immunol. 3, 221-227 (2002) https://doi.org/10.1038/ni0302-221
- Wang, P., McKay, B.S., Allen, J.B., and Jaffe, G.J. Effect of NF-kB inhibition on TNF-a -induced apoptosis. Invest. Ophthalmol. Vis. Sci. 45, 2438-2446 (2004) https://doi.org/10.1167/iovs.03-0805
- Chen, C., Edlstein, L.C., and Gelinas, C. The Rel/NF-kB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol. Cell. Biol. 20, 2687-2695 (2000) https://doi.org/10.1128/MCB.20.8.2687-2695.2000
- Stehlik, C., de Martin R., Kumabashiri, I., Schmid, J.A., Binder, B.R., and Lipp, J. Nuclear factor (NF)-kappa Bregulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J Exp Med. 188, 211-216 (1998) https://doi.org/10.1084/jem.188.1.211
- Wang, C.Y., Mayo, M.W., Korneluk, R.G., Goeddel, D.V., and Baldwin, Jr A.S. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP and c-IAP2 to suppress caspase-8 activation. Science 281, 1680-1683 (1998) https://doi.org/10.1126/science.281.5383.1680
- Berg, A.A, and Baltimore, D. An essential role for NF-kB in preventing TNF-a-induced cell death. Science 274, 782-274 (1996) https://doi.org/10.1126/science.274.5288.782
- Wang, C.Y., Mayo, M.W., and Baldwin, Jr A.S. TNF-and cancer therapy-induced apoptosis: potenitation by inhibition of NF-kappaB. Science 274, 784-787 (1996) https://doi.org/10.1126/science.274.5288.784
- Van Antewerp, D.J., Martin, S.J., Kafri, T, Green, D.R., and Verma, I.M. Suppression of TNF-a-induced apoptosis by NF-kB. Science 274, 787-789 (1996) https://doi.org/10.1126/science.274.5288.787
- Vasudevan, K.M., Gurumurthy, S., and Rangnekar V.M. Suppression of PTEN expression by NF-kB prevents apoptosis. Mol. Cell. Biol. 24,1007-1021 (2004) https://doi.org/10.1128/MCB.24.3.1007-1021.2004
- Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254 (1976) https://doi.org/10.1016/0003-2697(76)90527-3
- Cappellini, A., Tabellini, G., Zweyer, M., Bortul, R., Tazzari, P.L., Billi, A.M., Fala, F., Cocco, L., and Martelli, A.M. The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression. Leukemia 17, 2157-2167 (2003) https://doi.org/10.1038/sj.leu.2403111
- Altucci, L., Rossin, A., Raffelsberger, W., Reitmair, A., Chomienne, C., and Gronemeyer, H. Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL. Nat. Med.7, 680-686 (2001) https://doi.org/10.1038/89050
- Hisatake, J., O'Kelly, J., Uskokovic, M.R., Tomoyasu, S., and Koeffler, H.P. Novel vitamin D(3) analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D(3), that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells. Blood 97, 2427-2433 (2001) https://doi.org/10.1182/blood.V97.8.2427
- DiDonato, J.A., Hayakawa, M., Rothwarf, D.M., Zandi, E., and Karin, M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388, 548-554 (1997) https://doi.org/10.1038/41493
- Mercurio, F., Zhu, H., Murray, B.W., Shevchenko, A., Bennett, B.L., Li, J., Young, D.B., Barbosa, M., Mann, M., Manning, A., and Rao, A. IKK-1 and IKK-2: cytokineactivated IkappaB kinases essential for NF-kappaB activation. Science 278, 860-866 (1997) https://doi.org/10.1126/science.278.5339.860